We aimed at establishing the optimal scan time for nuclear myocardial perfusion imaging (MPI) on an ultrafast cardiac g-camera using a novel cadmium-zinc-telluride (CZT) solid-state detector technology. Methods: Twenty patients (17 male; BMI range, 21.7-35.5 kg/m 2 ) underwent 1-d 99m Tc-tetrofosmin adenosine stress and rest MPI protocols, each with a 15-min acquisition on a standard dual-detector SPECT camera. All scans were immediately repeated on an ultrafast CZT camera over a 6-min acquisition time and reconstructed from list-mode raw data to obtain scan durations of 1 min, 2 min, etc., up to a maximum of 6 min. For each of the scan durations, the segmental tracer uptake value (percentage of maximum myocardial uptake) from the CZT camera was compared by intraclass correlation with standard SPECT camera data using a 20-segment model, and clinical agreement was assessed per coronary territory. Scan durations above which no further relevant improvement in uptake correlation was found were defined as minimal required scan times, for which Bland-Altman limits of agreement were calculated. Results: Minimal required scan times were 3 min for low dose (r 5 0.81; P , 0.001; Bland-Altman, 211.4% to 12.2%) and 2 min for high dose (r 5 0.80; P , 0.001; Bland-Altman, 27.6% to 12.9%), yielding a clinical agreement of 95% and 97%, respectively. Conclusion: We have established the minimal scan time for a CZT solid-state detector system, which allows 1-d stress/rest MPI with a substantially reduced acquisition time resulting in excellent agreement with regard to uptake and clinical findings, compared with MPI from a standard dualhead SPECT g-camera.Key Words: clinical cardiology; SPECT; cadmium-zinc-telluride detector; myocardial perfusion imaging; ultrafast Ischemi c coronary artery disease is a major cause of morbidity and mortality in industrialized countries. The hemodynamic relevance of culprit lesions can be detected and quantified noninvasively by nuclear myocardial perfusion imaging (MPI), which has grown to become the most frequently used test in nuclear medicine (1) not only for accurate diagnosis of ischemic coronary artery disease but also for assessing prognosis and for imaging myocardial viability and function (2). However, time-consuming acquisitions and cumbersome MPI protocols, with the associated costs, impaired patient comfort, and radiation exposure, have been perceived as limitations. Several attempts to improve the MPI method by using iterative reconstruction algorithms (3,4), early-imaging protocols (5), or different tracers (6) provided valuable results but no breakthroughs translating into applications that improve daily clinical routine. The novel cadmium-zinc-telluride (CZT) detectors may have the potential to represent such a milestone in technical improvement of MPI. They offer a substantially improved count sensitivity as evidenced in preliminary reports (7) and first clinical studies (8,9) performed on a device (D-SPECT; Spectrum Dynamics) with 9 rotating CZT detectors. An alternative approach ...